Home › Funds › Tanager Wealth Management LLP › CADL
Tanager Wealth Management LLP position in CADL
CANDEL THERAPEUTICS INC · Health Care
Tanager Wealth Management LLP reported holding 198,175 shares of CADL (CANDEL THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.1M, representing 0.17% of its reported portfolio and ranking #46 among its reported holdings. Tanager Wealth Management LLP has disclosed CADL holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How Tanager Wealth Management LLP's CADL position evolved
Tanager Wealth Management LLP first disclosed a stake in CADL in Q2 2025 at 196,631 shares (US$995K). The position peaked in Q3 2026 at 198,175 shares, worth US$2.1M. Across 6 filings, Tanager Wealth Management LLP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 198,175 shares valued at US$2.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 196.63K | $994.95K | New |
| Q3 2025 | 198.18K | $1.01M | Add |
| Q4 2025 | 198.18K | $1.12M | Hold |
| Q1 2026 | 198.18K | $971.06K | Hold |
| Q2 2026 | 198.18K | $2.04M | Hold |
| Q3 2026 | 198.18K | $2.07M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CADL and 13F data
CADL (CANDEL THERAPEUTICS INC) is a Health Care company. 83 other funds we track also report a position in CADL — the largest reported positions include RTW INVESTMENTS, LP (US$66.1M), ACORN CAPITAL ADVISORS, LLC (US$36.0M), Portolan Capital Management, LLC (US$36.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CADL
- RTW INVESTMENTS, LP 6.42M sh · $66.15M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 3.50M sh · $36.03M · Q2 2026
- Portolan Capital Management, LLC 3.49M sh · $35.95M · Q2 2026
- Saturn V Capital Management LP 3.30M sh · $34.03M · Q2 2026
- Sands Capital Alternatives, LLC 405.84K sh · $4.18M · Q2 2026
- Kynam Capital Management, LP 96.74K sh · $996.43K · Q2 2026
More on Tanager Wealth Management LLP
FAQ
How long has Tanager Wealth Management LLP held CADL?
Tanager Wealth Management LLP has disclosed CADL holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Tanager Wealth Management LLP's current position in CADL?
As of Q3 2026, Tanager Wealth Management LLP holds 198.18K shares of CADL (CANDEL THERAPEUTICS INC), valued at $2.07M, representing 0.17% of its reported portfolio and ranking #46.
Has Tanager Wealth Management LLP been buying or selling CADL?
In the latest 13F filing (Q3 2026), Tanager Wealth Management LLP held unchanged its position in CADL. The position peaked in Q3 2026 at 198.18K shares.
Which other funds hold CADL?
Other major institutional holders of CADL include RTW INVESTMENTS, LP, ACORN CAPITAL ADVISORS, LLC, Portolan Capital Management, LLC, among 83 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.